Millipore Sigma Vibrant Logo

480415 NF023 - Calbiochem

View This Product on Sigma-Aldrich
480415
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

Empirical Formula
C₃₅H₂₀N₄O₂₁S₆ · 6Na

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
480415-10MGCN
在庫状況検索中…
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      樹脂アンプル 10 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewA suramin analog that acts as a selective and direct G-protein antagonist for α-subunits of the Go/Gi group (EC50 ~ 300 nM). Suppresses GTPγS binding to recombinant G-protein α-subunits. Acts by inhibiting the formation of the agonist-specific ternary complex (agonist/receptor/G-protein). NF023 does not interfere with the interaction between α-subunits and βγ-dimer but competes with the effector binding site. Also a P2X receptor antagonist (IC50 = 240 nM for P2X1; 8.5 µM for P2X3 receptor in rat muscle). Causes a concentration dependent inhibition of excitatory junction potentials (IC50 = 4.8 pM).
      Catalogue Number480415
      Brand Family Calbiochem®
      Synonyms8,8ʹ-[Carbonylbis(imino-3,1-phenylene)]bis-(1,3,5-naphthalenetrisulfonic Acid), 6Na, P2X Antagonist I, Purinergic Receptor P2X Antagonist I
      References
      ReferencesSnedden, P., et al. 2000. Br. J. Pharmacol. 129, 1089.
      Soto, F., et al. 1999. Neuropharmacology 38, 141.
      Beindle, W., et al. 1996. Mol. Pharmacol. 50, 415.
      Freissmuth, M., et al. 1996. Mol. Pharmacol. 49, 602.
      Product Information
      ATP CompetitiveN
      FormWhite to off-white solid
      Hill FormulaC₃₅H₂₀N₄O₂₁S₆ · 6Na
      Chemical formulaC₃₅H₂₀N₄O₂₁S₆ · 6Na
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Targetα-subunits of the Go/Gi group of G-protein
      Primary Target IC<sub>50</sub>240 nM for P2X1; 8.5 µM for P2X3 receptor in rat muscle; 4.8 pM in the inhibition of excitatory junction potentials; EC50 ~ 300 nM as G-protein antagonist for α-subunits of the Go/Gi group
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Avoid freeze/thaw cycles of solutions.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      480415-10MGCN 04055977201345

      Documentation

      NF023 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      NF023 - Calbiochem 試験成績書(CoA)

      タイトルロット番号
      480415

      参考資料

      参考資料の概要
      Snedden, P., et al. 2000. Br. J. Pharmacol. 129, 1089.
      Soto, F., et al. 1999. Neuropharmacology 38, 141.
      Beindle, W., et al. 1996. Mol. Pharmacol. 50, 415.
      Freissmuth, M., et al. 1996. Mol. Pharmacol. 49, 602.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision19-June-2018 JSW
      Synonyms8,8ʹ-[Carbonylbis(imino-3,1-phenylene)]bis-(1,3,5-naphthalenetrisulfonic Acid), 6Na, P2X Antagonist I, Purinergic Receptor P2X Antagonist I
      DescriptionA suramin analog that acts as a selective G-protein antagonist for α-subunits of the Go/Gi group (EC50 ~300 nM). Suppresses GTPγS binding to recombinant G-protein α-subunits. Acts by inhibiting the formation of the agonist-specific ternary complex (agonist/receptor/G-protein). NF023 does not interfere with the interaction between α-subunits βγ-dimer but competes with the effector binding site. Also a P2X receptor antagonist (IC50=0.24 µM for P2X1; 8.5 µM for P2X3 receptor in rat muscle).
      FormWhite to off-white solid
      Intert gas (Yes/No) Packaged under inert gas
      Chemical formulaC₃₅H₂₀N₄O₂₁S₆ · 6Na
      Structure formulaStructure formula
      Purity≥95% by HPLC
      SolubilityH₂O
      Storage +2°C to +8°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Avoid freeze/thaw cycles of solutions.
      Toxicity Standard Handling
      ReferencesSnedden, P., et al. 2000. Br. J. Pharmacol. 129, 1089.
      Soto, F., et al. 1999. Neuropharmacology 38, 141.
      Beindle, W., et al. 1996. Mol. Pharmacol. 50, 415.
      Freissmuth, M., et al. 1996. Mol. Pharmacol. 49, 602.